Reuters logo
CORRECTED-BRIEF-Merck KGaA, Pfizer present positive mid-stage data on merkel cell carcinoma drug at ASCO
2016年6月6日 / 下午1点27分 / 1 年前

CORRECTED-BRIEF-Merck KGaA, Pfizer present positive mid-stage data on merkel cell carcinoma drug at ASCO

(Corrects to clarify drug is jointly developed by Pfizer and Merck KGaA)

June 6 (Reuters) - Merck KGaA and Pfizer Inc :

* Say pivotal avelumab study shows positive results in metastatic merkel cell carcinoma

* Say plan to submit to regulatory authorities based on these results from avelumab study Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below